Aravive To Participate in Piper’s 34th Annual Healthcare Conference

November 21, 2022

https://www.globenewswire.com/news-release/2022/11/21/2559726/30446/en/Aravive-To-Participate-in-Piper-s-34th-Annual-Healthcare-Conference.html

HOUSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and Rudy Howard, Chief Financial Officer will be presenting a corporate overview and participating in 1×1 meetings at the Piper 34th Annual Healthcare Conference being held on November 29 – December 1, 2022 in New York, NY.

Read more at globenewswire.com

Related news for (ARAV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.